•  
  •  
  •  
  •  

2025-10-07 20:01:32

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  INE031B01049

Stock Report

  • Ajanta Pharma Ltd approves buy back of 10,28,881 shares through tender offer
  • Ajanta Pharma Ltd receives final approval from US FDA for Topiramate Extended Release Capsules
  • Ajanta Pharma Ltd approves 1st interim dividend of Rs. 25
  • USFDA inspects Ajanta Pharma Ltd's Formulation facility at Dahej
  • Ajanta Pharma announces buyback of equity shares of Rs. 389 crore
  • Ajanta Pharma awarded 'India's Best Managed Companies' by Deloitte
  • Ajanta Pharma Ltd allots 4,27,08,385 bonus shares
  • Ajanta Pharma Ltd board approves 1:2 bonus issue
  • Ajanta Pharma Ltd board to consider bonus issue on May 10, 2022
  • Ajanta Pharma Ltd board approves buyback of shares at Rs. 2550
  • Ajanta Pharma Ltd board to consider buyback on Dec 28, 2021
  • Ajanta Pharma Ltd Board declares Interim Dividend of Rs. 9.50

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024